Go Pro

93,542 Shares in Globe Life Inc. $GL Purchased by Corient Private Wealth LP

Globe Life logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Corient Private Wealth LP acquired 93,542 Globe Life shares worth approximately $16.7 million, giving it a 0.12% stake. Institutional investors collectively own 81.61% of the insurer.
  • Globe Life reported quarterly revenue of $1.60 billion, up 8% year over year, but earnings per share of $3.61 fell short of analysts’ $3.67 estimate. The company issued fiscal 2026 EPS guidance of $15.55–$15.95.
  • The company authorized a $2.5 billion share-repurchase program covering up to 17.7% of outstanding shares and declared a quarterly dividend of $0.33 per share. Meanwhile, insiders sold 151,908 shares worth about $27.2 million during the quarter.
  • Five stocks we like better than Globe Life.

Corient Private Wealth LP acquired a new position in Globe Life Inc. (NYSE:GL - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 93,542 shares of the company's stock, valued at approximately $16,714,000. Corient Private Wealth LP owned about 0.12% of Globe Life at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the business. CYBER HORNET ETFs LLC bought a new position in Globe Life in the 2nd quarter worth about $28,000. Hilton Head Capital Partners LLC purchased a new stake in shares of Globe Life in the 4th quarter worth $30,000. MUFG Securities EMEA plc bought a new position in shares of Globe Life during the 2nd quarter worth $31,000. Torren Management LLC purchased a new position in shares of Globe Life during the fourth quarter valued at $37,000. Finally, Johnson Financial Group Inc. purchased a new position in shares of Globe Life during the second quarter valued at $39,000. Institutional investors own 81.61% of the company's stock.

Insider Buying and Selling at Globe Life

In related news, CEO Frank M. Svoboda sold 10,000 shares of the business's stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $166.68, for a total transaction of $1,666,800.00. Following the completion of the transaction, the chief executive officer owned 54,020 shares in the company, valued at $9,004,053.60. The trade was a 15.62% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Michael Clay Majors sold 37,000 shares of the stock in a transaction that occurred on Wednesday, July 29th. The shares were sold at an average price of $178.64, for a total transaction of $6,609,680.00. Following the sale, the executive vice president directly owned 53,518 shares of the company's stock, valued at $9,560,455.52. The trade was a 40.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 151,908 shares of company stock valued at $27,239,981. 2.11% of the stock is currently owned by corporate insiders.

Globe Life Trading Down 1.3%

GL opened at $173.41 on Friday. The firm has a market cap of $13.33 billion, a price-to-earnings ratio of 11.51 and a beta of 0.48. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.43. Globe Life Inc. has a 12 month low of $127.85 and a 12 month high of $191.55. The stock has a fifty day moving average price of $178.77 and a 200-day moving average price of $159.53.

Globe Life (NYSE:GL - Get Free Report) last issued its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing analysts' consensus estimates of $3.67 by ($0.06). Globe Life had a return on equity of 20.52% and a net margin of 19.58%.The company had revenue of $1.60 billion for the quarter, compared to analysts' expectations of $1.59 billion. During the same quarter last year, the company earned $3.05 earnings per share. The company's revenue for the quarter was up 8.0% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. As a group, equities research analysts anticipate that Globe Life Inc. will post 15.71 earnings per share for the current fiscal year.

Globe Life declared that its Board of Directors has initiated a share repurchase program on Monday, August 10th that allows the company to buyback $2.50 billion in outstanding shares. This buyback authorization allows the company to repurchase up to 17.7% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's management believes its stock is undervalued.

Globe Life Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Monday, October 5th will be given a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Monday, October 5th. Globe Life's dividend payout ratio is presently 8.76%.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on GL. Weiss Ratings lowered shares of Globe Life from a "buy (b)" rating to a "buy (b-)" rating in a research note on Monday, July 20th. Morgan Stanley raised their target price on shares of Globe Life from $181.00 to $208.00 and gave the company an "overweight" rating in a research report on Monday, July 6th. JPMorgan Chase & Co. boosted their price target on shares of Globe Life from $181.00 to $201.00 and gave the company an "overweight" rating in a report on Tuesday, July 21st. Jefferies Financial Group upped their price target on shares of Globe Life from $147.00 to $166.00 and gave the stock a "hold" rating in a research report on Friday, July 10th. Finally, Keefe, Bruyette & Woods dropped their price objective on shares of Globe Life from $192.00 to $190.00 and set an "outperform" rating on the stock in a research note on Friday, July 24th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $191.67.

Get Our Latest Analysis on GL

Globe Life Company Profile

(Free Report)

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

Featured Articles

Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GL - Free Report).

Institutional Ownership by Quarter for Globe Life (NYSE:GL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Globe Life Right Now?

Before you consider Globe Life, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.

While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines